Govt Job: For the post of Pharmacist at ECHS

The ECHS Central Organisation is located in Delhi and functions under the Chief of Staff Committee (COSC) through the AG and DGDC&W in Army HQ.

The Central organization is headed by Managing Director, ECHS, a serving Major General. There are 28 Regional Centres ECHS and 426 ECHS Polyclinics.

ECHS is also an attached office of the Dept of Ex-Servicemen Welfare (DoESW), Ministry of Defence (MoD) as are Directorate General Resettlement(DGR) and Kendriya Sainik Board (KSB).

Post: Pharmacist

Station Commander, Bhubaneswar invites applications for the following post for ECHS Polyclinic Bhubaneswar, for a period of one year, renewable for an additional year. Preference shall be given to ex-servicemen (ESM).

No of Posts: 02

Max Age Limit to apply: 56 Years

Basic Qualification: B.Pharmacy from a recognized institute or 10+2 with a Science stream (Physics, Chemistry, Biology from a recognized board) and an approved Diploma in Pharmacy from a Pharmacy Council of India-recognized institute.

Registered as pharmacist under Pharmacy Act 1948.

Remuneration : Rs.28,100/PM

Only hard copies of the application by post will be accepted. Special qualifications, if any, are to be mentioned in the application.

Duly completed application (with mobile number and email ID) and experience certificates are to be forwarded tc the following address – The Administrative Commandant, Station Headquarters, Bhubaneswar, Unit-04, Bidyut Marg, Bhubaneswar-751001 Note:- Application without requisite Documents is liable to be rejected.

The date and time of the interview will be intimated telephonically or by e-mail. Candidates are to bring original qualification/experience certificate(s) at the time of the interview.
No TA or DA is admissible for the interview.

The last date of receipt of the application is November 28, 2022 (Monday).

Related Posts

Diabetic drug metformin found to act on brain

NEW DELHI:  Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…

Hetero debuts semaglutide generic in emerging markets

New Delhi: Hyderabad-based drugmaker Hetero has announced the launch of its generic semaglutide portfolio in emerging international markets. In a phased global push, the company plans to roll out its…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Diabetic drug metformin found to act on brain

Diabetic drug metformin found to act on brain

Hetero debuts semaglutide generic in emerging markets

Hetero debuts semaglutide generic in emerging markets

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Stem cell therapy for autism illegal: NMC advisory

Stem cell therapy for autism illegal: NMC advisory

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework